{"id":14076,"date":"2019-05-02T07:19:01","date_gmt":"2019-05-02T07:19:01","guid":{"rendered":"http:\/\/kenes-exhibitions.com\/biomed\/?p=14076"},"modified":"2020-02-19T13:06:48","modified_gmt":"2020-02-19T13:06:48","slug":"if-pharma-looks-slow-to-adopt-ai-its-got-good-reason-expert-says","status":"publish","type":"post","link":"https:\/\/kenes-exhibitions.com\/biomed2021\/?p=14076","title":{"rendered":"If pharma looks slow to adopt AI, it&#8217;s got good reason, expert says"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"14076\" class=\"elementor elementor-14076\" data-elementor-settings=\"[]\">\n\t\t\t\t\t\t<div class=\"elementor-inner\">\n\t\t\t\t\t\t\t<div class=\"elementor-section-wrap\">\n\t\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-81fcc9b elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"81fcc9b\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t\t\t<div class=\"elementor-row\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-b2e5e1a\" data-id=\"b2e5e1a\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-column-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t<div class=\"elementor-widget-wrap\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-249ff22 elementor-widget elementor-widget-text-editor\" data-id=\"249ff22\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-text-editor elementor-clearfix\">\n\t\t\t\t\t<p>by\u00a0<a href=\"https:\/\/www.fiercepharma.com\/author\/carly-helfand\">Carly Helfand<\/a> |\u00a0<time datetime=\"2019-05-01T15:04:00Z\">May 1, 2019 11:04am | <a href=\"https:\/\/www.fiercepharma.com\/marketing\/if-pharma-looks-slow-to-adopt-ai-there-s-good-reason-expert\">FiercePharma<\/a><\/time><\/p><p><img loading=\"lazy\" class=\"alignnone size-large wp-image-14084\" src=\"https:\/\/kenes-exhibitions.com\/biomed2021\/\/wp-content\/uploads\/AImachine-learning-and-pharma-Biomed-2019-1024x658.jpg\" alt=\"AI,machine-learning-and-pharma-Biomed-2019\" width=\"1024\" height=\"658\" \/><\/p><p>And just because pharma may be moving more slowly than other industries doesn\u2019t mean it\u2019s shying away. On the contrary, Harel said, CytoReason\u2014which will present as part of the AI and Digital Health tracks next month <a href=\"https:\/\/kenes-exhibitions.com\/biomed2021\/\/\">at the MIXiii BIOMED conference in Tel Aviv<\/a>\u2014has seen \u201cmost large pharma companies very open\u201d to new technologies.<\/p><p>Source: https:\/\/www.fiercepharma.com\/marketing\/if-pharma-looks-slow-to-adopt-ai-there-s-good-reason-expert<\/p>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>by\u00a0Carly Helfand |\u00a0May 1, 2019 11:04am | FiercePharma And just because pharma may be moving more slowly than other industries doesn\u2019t mean it\u2019s shying away. On the contrary, Harel said, CytoReason\u2014which will present as part of the AI and Digital Health tracks next month at the MIXiii BIOMED conference in Tel Aviv\u2014has seen \u201cmost large [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":16800,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[31],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v16.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>If pharma looks slow to adopt AI, it&#039;s got good reason, expert says - Biomed 2021<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/kenes-exhibitions.com\/biomed2021\/?p=14076\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"If pharma looks slow to adopt AI, it&#039;s got good reason, expert says - Biomed 2021\" \/>\n<meta property=\"og:description\" content=\"by\u00a0Carly Helfand |\u00a0May 1, 2019 11:04am | FiercePharma And just because pharma may be moving more slowly than other industries doesn\u2019t mean it\u2019s shying away. On the contrary, Harel said, CytoReason\u2014which will present as part of the AI and Digital Health tracks next month at the MIXiii BIOMED conference in Tel Aviv\u2014has seen \u201cmost large [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/kenes-exhibitions.com\/biomed2021\/?p=14076\" \/>\n<meta property=\"og:site_name\" content=\"Biomed 2021\" \/>\n<meta property=\"article:published_time\" content=\"2019-05-02T07:19:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-02-19T13:06:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/kenes-exhibitions.com\/biomed\/wp-content\/uploads\/2019\/05\/MG_0483.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1600\" \/>\n\t<meta property=\"og:image:height\" content=\"1067\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/kenes-exhibitions.com\/biomed2021\/#website\",\"url\":\"https:\/\/kenes-exhibitions.com\/biomed2021\/\",\"name\":\"Biomed 2021\",\"description\":\"Biomed 2021 is the largest convention in Israel for Life Sciences and Technology\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":\"https:\/\/kenes-exhibitions.com\/biomed2021\/?s={search_term_string}\",\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/kenes-exhibitions.com\/biomed2021\/?p=14076#primaryimage\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/kenes-exhibitions.com\/biomed2021\/wp-content\/uploads\/2019\/05\/MG_0483.jpg\",\"contentUrl\":\"https:\/\/kenes-exhibitions.com\/biomed2021\/wp-content\/uploads\/2019\/05\/MG_0483.jpg\",\"width\":1600,\"height\":1067},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/kenes-exhibitions.com\/biomed2021\/?p=14076#webpage\",\"url\":\"https:\/\/kenes-exhibitions.com\/biomed2021\/?p=14076\",\"name\":\"If pharma looks slow to adopt AI, it's got good reason, expert says - Biomed 2021\",\"isPartOf\":{\"@id\":\"https:\/\/kenes-exhibitions.com\/biomed2021\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/kenes-exhibitions.com\/biomed2021\/?p=14076#primaryimage\"},\"datePublished\":\"2019-05-02T07:19:01+00:00\",\"dateModified\":\"2020-02-19T13:06:48+00:00\",\"author\":{\"@id\":\"https:\/\/kenes-exhibitions.com\/biomed2021\/#\/schema\/person\/20bba1963c64e501ea3769a2fcb5676b\"},\"breadcrumb\":{\"@id\":\"https:\/\/kenes-exhibitions.com\/biomed2021\/?p=14076#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/kenes-exhibitions.com\/biomed2021\/?p=14076\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/kenes-exhibitions.com\/biomed2021\/?p=14076#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"item\":{\"@type\":\"WebPage\",\"@id\":\"https:\/\/kenes-exhibitions.com\/biomed2021\/\",\"url\":\"https:\/\/kenes-exhibitions.com\/biomed2021\/\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"position\":2,\"item\":{\"@id\":\"https:\/\/kenes-exhibitions.com\/biomed2021\/?p=14076#webpage\"}}]},{\"@type\":\"Person\",\"@id\":\"https:\/\/kenes-exhibitions.com\/biomed2021\/#\/schema\/person\/20bba1963c64e501ea3769a2fcb5676b\",\"name\":\"DevOps\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/kenes-exhibitions.com\/biomed2021\/#personlogo\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a4e75d351bb93d1ea98c87bfedabf29e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a4e75d351bb93d1ea98c87bfedabf29e?s=96&d=mm&r=g\",\"caption\":\"DevOps\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","_links":{"self":[{"href":"https:\/\/kenes-exhibitions.com\/biomed2021\/index.php?rest_route=\/wp\/v2\/posts\/14076"}],"collection":[{"href":"https:\/\/kenes-exhibitions.com\/biomed2021\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kenes-exhibitions.com\/biomed2021\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kenes-exhibitions.com\/biomed2021\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kenes-exhibitions.com\/biomed2021\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=14076"}],"version-history":[{"count":2,"href":"https:\/\/kenes-exhibitions.com\/biomed2021\/index.php?rest_route=\/wp\/v2\/posts\/14076\/revisions"}],"predecessor-version":[{"id":16869,"href":"https:\/\/kenes-exhibitions.com\/biomed2021\/index.php?rest_route=\/wp\/v2\/posts\/14076\/revisions\/16869"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kenes-exhibitions.com\/biomed2021\/index.php?rest_route=\/wp\/v2\/media\/16800"}],"wp:attachment":[{"href":"https:\/\/kenes-exhibitions.com\/biomed2021\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=14076"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kenes-exhibitions.com\/biomed2021\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=14076"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kenes-exhibitions.com\/biomed2021\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=14076"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}